Ready 8-Ks
15
Latest filing
August 18, 2026, 8:00 AM ET
Top materiality
0.85
Event mix
other_material ×6 · earnings ×4 · m_and_a ×4
Sentiment
6 pos · 2 neg · 7 neu
Latest earnings
reported 2026-Q1
-
Nano Dimension Q2 revenue up 12% to $29M; sells MarkForged to Stratasys
Revenue $29.0M (+12.1% YoY); gross margin 45.9% vs 27.3% YoY.
-
Nano Dimension settles activist dispute; CEO Stehlin and three other directors resign, three new directors appointed
Settlement with Murchinson cancels July 31 EGM; four directors resign including CEO David Stehlin.
-
Nano Dimension terminates HQ lease, expects $25M net cash savings through 2031
Agreement to terminate corporate headquarters lease effective Dec 31, 2026; lease originally from MarkForged (2021) expiring 2031.
-
Nano Dimension provides update on proposed Infinite Epigenetics acquisition, values company at net cash plus 20% premium
Infinite Epigenetics is a commercial diagnostics platform with CLIA-certified lab, >120K samples, and >7,500 healthcare providers.
-
Nano Dimension signs non-binding term sheet to acquire Infinite Epigenetics for $890M stock consideration
Infinite valued at $890M; Nano valuation based on net cash plus 20% premium plus ~$20M for Essemtec.
-
Nano Dimension faces activist-led EGM; board backs only two of six proposals
Activist group (Murchinson, Nomis Bay, BPY, Boothbay funds, Oramed) demands EGM on July 31, 2026 in Waltham, MA.
-
Nano Dimension sells MarkForged to Stratasys for $42.5M cash, reduces annual burn by $15M
Nano Dimension sells MarkForged subsidiary to Stratasys (SSYS) for $42.5M in cash.
-
Nano Dimension board rejects Murchinson’s bid to replace three directors; strategic review continues
Murchinson filed an amended Schedule 13D, seeking to replace three of five directors, including two it previously nominated and the CEO.
-
Nano Dimension Q1 net loss $69.7M (incl. $40.4M impairment); revenue up 106% to $29.7M
Revenue $29.7M (+106% YoY); adjusted gross margin 45.9% vs. 43.3%.
-
Nano Dimension sells AME & Fabrica product lines to Inspira for up to $12.5M
Total consideration up to $12.5M: $2.0M cash upfront, up to $10.5M deferred based on 12-month performance.
-
Nano Dimension Q4 revenue up 142% to $35.3M; strategic review on track for Q2 2026
Full-year 2025 revenue $102.4M (+77.3% YoY); Q4 revenue $35.3M (+142.4% YoY).
-
Nano Dimension Q4 2025 preliminary revenue $35.0-35.5M, above guidance of $31.5-33.5M
Q4 2025 preliminary revenue $35.0-35.5M, exceeding prior guidance of $31.5-33.5M; strength in defense, aerospace, automotive.